Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-severe Glabellar Lines”

84 trials

Showing 20 of 84 results

Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)Study completedNCT05463965
What this trial is testing

Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Galderma R&D 605
Large-scale testing (Phase 3)Study completedNCT04247074
What this trial is testing

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Who this might be right for
Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
Galderma R&D 413
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Large-scale testing (Phase 3)Study completedNCT00770211
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 271
Not applicableStudy completedNCT05481931
What this trial is testing

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 756
Large-scale testing (Phase 3)Study completedNCT04249583
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 300
Testing effectiveness (Phase 2)Study completedNCT04281095
What this trial is testing

A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT05298449
What this trial is testing

Phase 2 of HU-045 in Glabellar Lines

Who this might be right for
Glabellar Lines
Huons Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01333397
What this trial is testing

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Ipsen 176
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Testing effectiveness (Phase 2)Study completedNCT04096326
What this trial is testing

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Who this might be right for
Glabellar Lines
Allergan 198
Early research (Phase 1)Study completedNCT06212960
What this trial is testing

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 20
Large-scale testing (Phase 3)Looking for participantsNCT06205797
What this trial is testing

To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)

Who this might be right for
Glabellar Lines
Huons Biopharma 312
Testing effectiveness (Phase 2)Study completedNCT06199336
What this trial is testing

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 190
Testing effectiveness (Phase 2)Study completedNCT02961673
What this trial is testing

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Huons Co., Ltd. 57
Early research (Phase 1)Study completedNCT05292638
What this trial is testing

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Who this might be right for
Glabellar Lines
CKD Bio Corporation 30
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Large-scale testing (Phase 3)Study completedNCT01629875
What this trial is testing

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Who this might be right for
Moderate to Severe Glabellar Line
Daewoong Pharmaceutical Co. LTD. 268
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation